CASI Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CASI Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
15 Jul 24	BuyUS$1,500,000	Wei-Wu He	Individual		300,000	US$5.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CASI?
Owner Type	Number of Shares	Ownership Percentage
Institutions	386,750	2.57%
Individual Insiders	775,224	5.15%
Private Companies	908,788	6.04%
General Public	6,386,600	42.4%
VC/PE Firms	6,591,143	43.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13%.

Top Shareholders

Top 25 shareholders own 57.56% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.5%	IDG Capital	1,873,731	US$5.0m	0%	0.3%
8.79%	Panacea Venture Management Co., Ltd.	1,323,429	US$3.5m	30%	7.65%
8.7%	Foresite Capital Management, LLC	1,309,383	US$3.5m	0%	1.25%
7.29%	Emerging Technology Partners, LLC	1,097,341	US$2.9m	0%	100.0%
6.56%	VR Adviser, LLC	987,259	US$2.6m	784%	0.14%
6.04%	Wealth Strategy Holding Ltd	908,788	US$2.4m	0%	no data
5.07%	Wei-Wu He	763,209	US$2.0m	11.1%	no data
0.88%	Wellington Shields Capital Management, LLC	132,308	US$350.6k	0%	0.04%
0.43%	ADAR1 Capital Management, LLC	64,835	US$171.8k	687%	0.03%
0.33%	Huiying Memorial Foundation, Endowment Arm	50,000	US$132.5k	0%	no data
0.28%	Renaissance Technologies LLC	41,500	US$110.0k	1.72%	no data
0.2%	Woodline Partners LP	30,532	US$80.9k	0%	no data
0.15%	Citadel Advisors LLC	22,714	US$60.2k	0%	no data
0.13%	Geode Capital Management, LLC	19,363	US$51.3k	-12.9%	no data
0.098%	UBS Asset Management AG	14,681	US$38.9k	29.7%	no data
0.066%	Zuie-Chin Huang	10,000	US$26.5k	0%	no data
0.046%	Brewin Dolphin Wealth Management Limited	6,900	US$18.3k	0%	no data
0.013%	Wei Zhang	2,015	US$5.3k	0%	no data
0.013%	Dimensional Fund Advisors LP	1,927	US$5.1k	0%	no data
0.0096%	Morgan Stanley, Investment Banking and Brokerage Investments	1,440	US$3.8k	0%	no data
0.0034%	Wells Fargo & Company, Securities and Brokerage Investments	506	US$1.3k	0%	no data
0.002%	BlackRock, Inc.	296	US$785.6	0%	no data
0.00066%	West Paces Advisors, Inc.	100	US$263.2	0%	no data
0.00019%	Merrill Lynch & Co. Inc., Banking Investments	28	US$75.8	-47.2%	no data
0.00017%	JPMorgan Chase & Co, Brokerage and Securities Investments	25	US$67.8	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 14:16
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CASI Pharmaceuticals, Inc. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Justin Zelin	BTIG
Nathaniel Calloway	Edison Investment Research
Ching-Yi Lin	H.C. Wainwright & Co.